JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265411

Human SLC52A2 (GPR172A/PAR1) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SLC52A2 KO cell line available to order. KO validated by. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and 1 bp insertion in exon 2. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.

View Alternative Names

GPR172A, PERV-A receptor 1, Porcine endogenous retrovirus A receptor 1, Protein GPR172A, RFT3, RFT3_HUMAN, Riboflavin transporter 3, hRFT3

2 Images
Sanger Sequencing - Human SLC52A2 (GPR172A/PAR1) knockout HeLa cell line (AB265411)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC52A2 (GPR172A/PAR1) knockout HeLa cell line (AB265411)

Allele-2 : 1 bp insertion in exon 2.

Sanger Sequencing - Human SLC52A2 (GPR172A/PAR1) knockout HeLa cell line (AB265411)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC52A2 (GPR172A/PAR1) knockout HeLa cell line (AB265411)

Allele-1 : 1 bp deletion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and 1 bp insertion in exon 2

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265411-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265411-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265411 Human SLC52A2 (GPR172A/PAR1) knockout HeLa cell line", "number":"AB265411-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265411-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265411-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265411 Human SLC52A2 (GPR172A/PAR1) knockout HeLa cell line", "number":"AB265411-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265411-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265411 Human SLC52A2 (GPR172A/PAR1) knockout HeLa cell line", "number":"AB265411-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265411-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265411 Human SLC52A2 (GPR172A/PAR1) knockout HeLa cell line", "number":"AB265411-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC52A2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GPR172A also known as PAR1 is a G protein-coupled receptor with roles in various cellular processes. Its molecular mass is approximately 48 kDa. This protein is expressed in many tissues including the liver kidney and brain. As a receptor it interacts with G proteins to transmit signals from the outside of the cell to the inside influencing the cell's response to external stimuli.
Biological function summary

GPR172A/PAR1 plays an important role in regulating blood clotting and inflammation. It is part of a signaling complex that includes thrombin a serine protease. This complex is important for activating platelets which are cells involved in the blood clotting process. By activating platelets GPR172A/PAR1 helps control bleeding and wound healing.

Pathways

The protein is involved in both the coagulation and inflammatory pathways. In the coagulation pathway it works alongside other proteins like thrombin and fibrinogen contributing to clot formation. In inflammation GPR172A/PAR1 interacts with proteins such as NF-kB helping to regulate inflammatory responses and cytokine production which are important for immune defense and tissue repair.

GPR172A/PAR1 has a connection to cardiovascular diseases and inflammatory disorders. Its role in promoting blood clot formation links it to conditions like thrombosis where abnormal clotting can lead to dangerous blockages in blood vessels. GPR172A/PAR1 also relates to inflammatory disorders through its interaction with inflammatory proteins such as NF-kB. Abnormal activity of this receptor can lead to excessive inflammation contributing to diseases like rheumatoid arthritis.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com